Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Yearly performance comparison of index funds helps you rank funds by year, track changes, and refine your allocation strategy today.
19,588 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
The UFO ETF surged on Virgin Galactic strength, but a heavy tilt toward a single stock raises concentration concerns....
A price about break out in AI pricing is emerging as competition intensifies. Investors are counting on who can monet...
A Qualys director recently sold shares worth about $104,000 in an open-market move. Learn how to interpret insider sa...
Two chipmakers with different playbooks face the 2026 market. This guide breaks down Marvell Technology and Semtech, ...
OpenAI teams with Broadcom to introduce its first custom AI accelerator, Jalapeño. The move signals a broader strateg...
July brought mixed signals to the stock market today as entertainment stocks like AMC faced dilution concerns while t...
A tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
An executive chair's sizable stock sale draws attention. This piece explains what the numbers mean, how to read insid...
A notable stake increase in Shift4 Payments hints at growing conviction from Maestria Partners. This deep dive explai...
A new wave of crypto optimism centers on greener tech and Solana’s efficiency. This piece breaks down what back? cryp...
Wingstop has flirted with 3,000 locations, but the real test for investors is what happens next. This article examine...